Clinical Trials
46 trialsReal-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
HistoSonics, Inc.
DP-04
AstraZeneca
ELEPHAS-02
Elephas
A Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Target PharmaSolutions, Inc.
NOLA (NeuWave Observational Liver Ablation) Registry
Ethicon, Inc.
PTC-IMPACT
Gene Solutions
SCORE
Natera, Inc.
ELEPHAS-05
Elephas
Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma
Takeda
Precision1
Perspectum
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Exact Sciences Corporation
DELFI-L101
Delfi Diagnostics Inc.
K-ACCELERATE
Gene Solutions
Seravue
ImCare Biotech
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
INSPIRE
Singlera Genomics Inc.
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Viome
ROOT
Taproot Health
RADIANT
DxTerity Diagnostics
LIVER-1
Helio Genomics
PAN-study: Pan-Cancer Early Detection Study (PAN)
Owlstone Ltd
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Bayer
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
Techsomed Medical Technologies LTD
CADENCE
MiRXES Pte Ltd
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants
Eisai Inc.
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
Genetron Health
Characterization of Methylation Patterns in Hepatocellular Carcinoma
Nucleix Ltd.
READ90Y
Boston Scientific Corporation
PIONEER
SpeciCare
SORAGO-HCC
Bayer
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Epigenomics, Inc
SUCCESS
Bayer
HCC Patient Preferences in Japan
Bayer
GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start
Bayer
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
Bayer
STELLA
Bayer
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Pathfinder Therapeutics
Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures
Pathfinder Therapeutics
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Pathfinder Therapeutics
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Pathfinder Therapeutics
Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer
Pathfinder Therapeutics